Summary
Gilead Sciences, Inc. (GILD) filed an 8-K on July 30, 2020, to report its financial results for the quarter ended June 30, 2020. The primary purpose of this filing is to furnish a press release announcing these results, which provides both GAAP and non-GAAP financial information. Investors should note that while non-GAAP measures are presented as management believes they offer useful insights for operational and financial planning, they are not prepared under comprehensive accounting rules and should be analyzed alongside the company's official GAAP financial statements. The press release, included as Exhibit 99.1, details Gilead's performance during the second quarter of 2020. Investors interested in the specific financial figures, such as revenue, earnings per share, and operational performance, should refer to this press release. A reconciliation between GAAP and non-GAAP financial measures is also provided within the press release, allowing for a comprehensive understanding of the company's financial health.
Key Highlights
- 1Gilead Sciences announced its financial results for the quarter ended June 30, 2020, via a press release filed as part of an 8-K filing.
- 2The filing includes both GAAP (Generally Accepted Accounting Principles) and non-GAAP financial information.
- 3Gilead's management believes non-GAAP information is useful for investors and for internal operational, budgeting, and financial planning.
- 4Investors are advised to use non-GAAP information to supplement, not replace, the understanding of results reported under GAAP.
- 5A reconciliation between GAAP and non-GAAP financial measures is available on pages 12-14 of the press release.
- 6The press release is filed as Exhibit 99.1 to the 8-K report.
- 7This filing information is not considered 'filed' for purposes of Section 18 of the Exchange Act or incorporated by reference into other filings.